Next generation probiotics in disease amelioration

Tlaskalova-Hogenova, 2011, The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases, Cell Mol Immunol, 8, 110, 10.1038/cmi.2010.67 Ivanov, 2012, Intestinal commensal microbes as immune modulators, Cell Host Microbe, 12, 496, 10.1016/j.chom.2012.09.009 Lin, 2014, Impact of the gut microbiota, prebiotics, and probiotics on human health and disease, Biomed J, 37, 259, 10.4103/2319-4170.138314 Zhu, 2018, Targeting pattern-recognition receptors to discover new small molecule immune modulators, Eur J Med Chem, 144, 82, 10.1016/j.ejmech.2017.12.026 Mogensen, 2009, Pathogen recognition and inflammatory signaling in innate immune defenses, Clin Microbiol Rev, 22, 240, 10.1128/CMR.00046-08 Willing, 2010, The role of the immune system in regulating the microbiota, Gut Microb, 1, 213, 10.4161/gmic.1.4.12520 Belkaid, 2014, Role of the microbiota in immunity and inflammation, Cell, 157, 121, 10.1016/j.cell.2014.03.011 Kelly, 2015, Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders, Front Cell Neurosci, 9, 392, 10.3389/fncel.2015.00392 Guo, 2016, Subclinical-dose endotoxin sustains low-grade inflammation and exacerbates steatohepatitis in high-fat diet-fed mice, J Immunol, 196, 2300, 10.4049/jimmunol.1500130 Chang, 2015, Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota, Nat Commun, 6, 7489, 10.1038/ncomms8489 Woting, 2016, The intestinal microbiota in metabolic disease, Nutrients, 8, 202, 10.3390/nu8040202 Hooper, 2012, Interactions between the microbiota and the immune system, Science, 336, 1268, 10.1126/science.1223490 Cani, 2018, Human gut microbiome: hopes, threats and promises, Gut, 67, 1716, 10.1136/gutjnl-2018-316723 Husted, 2017, GPCR-mediated signaling of metabolites, Cell Metabol, 25, 777, 10.1016/j.cmet.2017.03.008 Kimura, 2014, The SCFA receptor GPR43 and energy metabolism, Front Endocrinol (Lausanne), 5, 85, 10.3389/fendo.2014.00085 Peng, 2009, Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers, J Nutr, 139, 1619, 10.3945/jn.109.104638 Glover, 2016, Oxygen metabolism and barrier regulation in the intestinal mucosa, J Clin Invest, 126, 3680, 10.1172/JCI84429 Byndloss, 2017, Microbiota-activated PPAR-gamma signaling inhibits dysbiotic Enterobacteriaceae expansion, Science, 357, 570, 10.1126/science.aam9949 Clarke, 2014, Minireview: gut microbiota: the neglected endocrine organ, Mol Endocrinol, 28, 1221, 10.1210/me.2014-1108 Olveira, 2016, An update on probiotics, prebiotics and symbiotics in clinical nutrition, Endocrinol Nutr, 63, 482, 10.1016/j.endonu.2016.07.006 Bottacini, 2017, Omics of bifidobacteria: research and insights into their health-promoting activities, Biochem J, 474, 4137, 10.1042/BCJ20160756 Hiippala, 2018, The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation, Nutrients, 10, 10.3390/nu10080988 Bilen, 2018, The contribution of culturomics to the repertoire of isolated human bacterial and archaeal species, Microbiome, 6, 94, 10.1186/s40168-018-0485-5 Ross, 2008, Considerations in the development of live biotherapeutic products for clinical use, Curr Issues Mol Biol, 10, 13 Felis, 2007, Taxonomy of lactobacilli and bifidobacteria, Curr Issues Intest Microbiol, 8, 44 Russell, 2011, Metabolic activities and probiotic potential of bifidobacteria, Int J Food Microbiol, 149, 88, 10.1016/j.ijfoodmicro.2011.06.003 Delcenserie, 2007, Description of a new species, Bifidobacterium crudilactis sp. nov., isolated from raw milk and raw milk cheeses, Syst Appl Microbiol, 30, 381, 10.1016/j.syapm.2007.01.004 Sivan, 2015, Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy, Science, 350, 1084, 10.1126/science.aac4255 Kahouli, 2013, Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives, J Med Microbiol, 62, 1107, 10.1099/jmm.0.048975-0 Le Leu, 2010, Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats, Carcinogenesis, 31, 246, 10.1093/carcin/bgp197 Roller, 2007, Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients, Br J Nutr, 97, 676, 10.1017/S0007114507450292 Rong, 2017, Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8(+) T cell response and better prognosis in HBV-related hepatocellular carcinoma, Exp Cell Res, 358, 352, 10.1016/j.yexcr.2017.07.009 Fu, 2005, Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer, Cancer Gene Ther, 12, 133, 10.1038/sj.cgt.7700758 Li, 2010, Selenium-Bifidobacterium longum as a delivery system of endostatin for inhibition of pathogenic bacteria and selective regression of solid tumor, Exp Ther Med, 1, 129, 10.3892/etm_00000022 De Vadder, 2016, Microbiota-produced succinate improves glucose homeostasis via intestinal gluconeogenesis, Cell Metabol, 24, 151, 10.1016/j.cmet.2016.06.013 Pedersen, 2016, Human gut microbes impact host serum metabolome and insulin sensitivity, Nature, 535, 376, 10.1038/nature18646 Cani, 2017, Next-generation beneficial microbes: the case of Akkermansia muciniphila, Front Microbiol, 8, 1765, 10.3389/fmicb.2017.01765 Everard, 2013, Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity, Proc Natl Acad Sci U S A, 110, 9066, 10.1073/pnas.1219451110 Plovier, 2017, A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice, Nat Med, 23, 107, 10.1038/nm.4236 Cani, 2014, Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond, Diabetes Metab, 40, 246, 10.1016/j.diabet.2014.02.004 Wang, 2018, Modulation of gut microbiota: a novel paradigm of enhancing the efficacy of programmed death-1 and programmed death ligand-1 blockade therapy, Front Immunol, 9, 374, 10.3389/fimmu.2018.00374 Schneeberger, 2015, Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice, Sci Rep, 5, 16643, 10.1038/srep16643 Heintz-Buschart, 2018, The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder, Mov Disord, 33, 88, 10.1002/mds.27105 Erturk-Hasdemir, 2018, Finding a needle in a haystack: Bacteroides fragilis polysaccharide A as the archetypical symbiosis factor, Ann N Y Acad Sci, 1417, 116, 10.1111/nyas.13660 Huang, 2011, The human commensal Bacteroides fragilis binds intestinal mucin, Anaerobe, 17, 137, 10.1016/j.anaerobe.2011.05.017 Sears, 2008, Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea, Clin Infect Dis, 47, 797, 10.1086/591130 Round, 2010, Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota, Proc Natl Acad Sci U S A, 107, 12204, 10.1073/pnas.0909122107 Dasgupta, 2014, Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms, Cell Host Microbe, 15, 413, 10.1016/j.chom.2014.03.006 Lukiw, 2016, Bacteroides fragilis lipopolysaccharide and inflammatory signaling in alzheimer's disease, Front Microbiol, 7, 1544, 10.3389/fmicb.2016.01544 Goodrich, 2014, Human genetics shape the gut microbiome, Cell, 159, 789, 10.1016/j.cell.2014.09.053 Goodrich, 2016, Genetic determinants of the gut microbiome in UK twins, Cell Host Microbe, 19, 731, 10.1016/j.chom.2016.04.017 Miquel, 2013, Faecalibacterium prausnitzii and human intestinal health, Curr Opin Microbiol, 16, 255, 10.1016/j.mib.2013.06.003 Duncan, 2002, Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov, Int J Syst Evol Microbiol, 52, 2141 Wrzosek, 2013, Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent, BMC Biol, 11, 61, 10.1186/1741-7007-11-61 Park, 2018, Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance, Exp Mol Med, 50, 109, 10.1038/s12276-018-0130-1 Gopalakrishnan, 2018, Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients, Science, 359, 97, 10.1126/science.aan4236 Chaput, 2017, Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab, Ann Oncol, 28, 1368, 10.1093/annonc/mdx108 Wu, 2019, Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis, Gut, 68, 248, 10.1136/gutjnl-2017-315458 Kanauchi, 2006, Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity, World J Gastroenterol, 12, 1071, 10.3748/wjg.v12.i7.1071 Mulanovich, 2016, Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies, AIDS, 30, 2653, 10.1097/QAD.0000000000001240 Routy, 2018, Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors, Science, 359, 91, 10.1126/science.aan3706 Daillere, 2016, Enterococcus hirae and barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects, Immunity, 45, 931, 10.1016/j.immuni.2016.09.009 Bourafa, 2015, Enterococcus hirae, an unusual pathogen in humans causing urinary tract infection in a patient with benign prostatic hyperplasia: first case report in Algeria, New Microbes New Infect, 8, 7, 10.1016/j.nmni.2015.08.003 Matson, 2018, The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients, Science, 359, 104, 10.1126/science.aao3290 Derosa, 2018, The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1, OncoImmunology, 7, e1434468, 10.1080/2162402X.2018.1434468 Ulrich, 2017, Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: a systematic review, Heliyon, 3, e00473, 10.1016/j.heliyon.2017.e00473 Lipowski, 2008, [Burkholderia cepacia: a new pathogen causing nosocomial infections], Przegl Epidemiol, 62, 7 Pitt, 2017, Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota, OncoImmunology, 6, e1132137, 10.1080/2162402X.2015.1132137